Rezultati pretrage - Corral, Jesus
- Prikaz rezultata 1 – 9 od 9
-
1
Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients od Remon, Jordi, Mezquita, Laura, Corral, Jesús, Vilariño, Noelia, Reguart, Noemi
Izdano 2018Tekst -
2
-
3
Torcular herophili and lateral sinus thrombosis: An atypical presentation of Lemièrre's syndrome od Baltasar-Corral, Jesús, Martín-Rojas, Reyes María, Parra-Virto, Alejandro, Galeano-Valle, Francisco, Del-Valle-Diéguez, Mariano, Del-Toro-Cervera, Jorge, Demelo-Rodríguez, Pablo
Izdano 2019Tekst -
4
Molecular biomarkers in early stage lung cancer od Rodríguez, María, Ajona, Daniel, Seijo, Luis M., Sanz, Julián, Valencia, Karmele, Corral, Jesús, Mesa-Guzmán, Miguel, Pío, Rubén, Calvo, Alfonso, Lozano, María D., Zulueta, Javier J., Montuenga, Luis M.
Izdano 2021Tekst -
5
SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021) od Echavarria, Isabel, Carrión Galindo, J. Rafael, Corral, Jesús, Diz Taín, María Pilar, Henao Carrasco, Fernando, Iranzo González-Cruz, Vega, Mielgo-Rubio, Xabier, Quintanar, Teresa, Rivas Corredor, Carlos, Pérez Segura, Pedro
Izdano 2022Tekst -
6
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating... od Mok, Tony S., Cheng, Ying, Zhou, Xiangdong, Lee, Ki Hyeong, Nakagawa, Kazuhiko, Niho, Seiji, Chawla, Alka, Rosell, Rafael, Corral, Jesus, Migliorino, Maria Rita, Pluzanski, Adam, Noonan, Kay, Tang, Yiyun, Pastel, Malaika, Wilner, Keith D., Wu, Yi-Long
Izdano 2020Tekst -
7
C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19 od Giner-Galvañ, Vicente, Pomares-Gómez, Francisco José, Quesada, José Antonio, Rubio-Rivas, Manuel, Tejada-Montes, Javier, Baltasar-Corral, Jesús, Taboada-Martínez, María Luisa, Sánchez-Mesa, Blanca, Arnalich-Fernández, Francisco, Del Corral-Beamonte, Esther, López-Sampalo, Almudena, Pesqueira-Fontán, Paula María, Fernández-Garcés, Mar, Gómez-Huelgas, Ricardo, Ramos-Rincón, José Manuel
Izdano 2022Tekst -
8
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours od de Bono, Johann, Lin, Chia-Chi, Chen, Li-Tzong, Corral, Jesus, Michalarea, Vasiliki, Rihawi, Karim, Ong, Michael, Lee, Jih-Hsiang, Hsu, Chih-Hung, Yang, James Chih-Hsin, Shiah, Her-Shyong, Yen, Chia-Jui, Anthoney, Alan, Jove, Maria, Buschke, Susanne, Fuertig, René, Schmid, Ulrike, Goeldner, Rainer-Georg, Strelkowa, Natalja, Huang, Dennis Chin-Lun, Bogenrieder, Thomas, Twelves, Chris, Cheng, Ann-Lii
Izdano 2020Tekst -
9
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO) od Morgan, Gilberto, Lambertini, Matteo, Kourie, Hampig Raphael, Amaral, Teresa, Argiles, Guillem, Banerjee, Susana, Cardone, Claudia, Corral, Jesus, De Mattos-Arruda, Letticia, öztürk, Akif, Petrova, Mila, Poulsen, Laurids, Strijbos, Michiel, Tyulyandina, Alexandra, Vidra, Radu, Califano, Raffaele, de Azambuja, Evandro, Garrido Lopez, Pilar, Guarneri, Valentina, Reck, Martin, Moiseyenko, Vladimir, Martinelli, Erika, Douillard, Jean-Yves, Stahel, Rolf, Voest, Emile, Arnold, Dirk, Cardoso, Fatima, Casali, Paolo, Cervantes, Andrés, Eggermont, Alexander M M, Eniu, Alexandru, Jassem, Jacek, Pentheroudakis, George, Peters, Solange, McGregor, Keith, Rauh, Stefan, Zielinski, Christoph C, Ciardiello, Fortunato, Tabernero, Josep, Preusser, Matthias
Izdano 2016Tekst